Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
fda
7
×
life sciences
national blog main
clinical trials
deals
boston blog main
boston top stories
san diego blog main
san diego top stories
startups
medical device
national top stories
new york blog main
raleigh-durham blog main
san francisco blog main
san francisco top stories
alexion pharmaceuticals
avexis
boston
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
investing
macrolide pharmaceuticals
national
new york top stories
nonalcoholic steatohepatitis
raleigh-durham top stories
san diego
seattle blog main
seattle top stories
texas blog main
texas top stories
vaccines
What
disease
7
×
drug
medicines
control
deal
fda
lung
nash
news
pharma
pharmaceuticals
roundup
therapeutics
according
add
akcea
alternative
approved
autoimmune
bacteria
bio
biopharma
biotech
building
business
called
candidate
carbidopa
cases
caught
causing
centers
cigarettes
combination
companies
company
daily
deaths
developer
dicerna
Language
unset
Current search:
biotech
×
disease
×
fda
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed